J
Julia Potter
Researcher at Ontario Institute for Cancer Research
Publications - 13
Citations - 5964
Julia Potter is an academic researcher from Ontario Institute for Cancer Research. The author has contributed to research in topics: Mutant & Embryonic stem cell. The author has an hindex of 13, co-authored 13 publications receiving 5784 citations. Previous affiliations of Julia Potter include University of Toronto & Amgen.
Papers
More filters
Journal ArticleDOI
Differential requirement for caspase 9 in apoptotic pathways in vivo
Razqallah Hakem,Razqallah Hakem,Anne Hakem,Anne Hakem,Gordon S. Duncan,Gordon S. Duncan,Jeffrey T. Henderson,Minna Woo,Minna Woo,Maria S. Soengas,Andrew E. H. Elia,Andrew E. H. Elia,José Luis de la Pompa,José Luis de la Pompa,David Kägi,David Kägi,Wilson Khoo,Wilson Khoo,Julia Potter,Julia Potter,Ritsuko Yoshida,Ritsuko Yoshida,Stephen Kaufman,Scott W. Lowe,Josef M. Penninger,Josef M. Penninger,Tak W. Mak,Tak W. Mak +27 more
TL;DR: Comparison of the requirement for Casp9 and Casp3 in different apoptotic settings indicates the existence of at least four different apoptosis pathways in mammalian cells.
Journal ArticleDOI
Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
José Luis de la Pompa,Luika A. Timmerman,Hiroaki Takimoto,Hiroki Yoshida,Andrew J. Elia,Enrique Samper,Julia Potter,Andrew Wakeham,Luc E. M. Marengere,B. Lowell Langille,Gerald R. Crabtree,Tak W. Mak +11 more
TL;DR: It is reported here that mice bearing a disruption in the NF-ATc gene fail to develop normal cardiac valves and septa and die of circulatory failure before day 14.5 of development, indicating that the Ca2+/calcineurin/NF-atc signalling pathway is essential for normal cardiac valve and septum morphogenesis and hence, NF- ATc and its regulatory pathways are candidates for genetic defects underlying congenital human heart disease.
Journal ArticleDOI
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Razqallah Hakem,Razqallah Hakem,José Luis de la Pompa,José Luis de la Pompa,Christian Sirard,Christian Sirard,Rong Mo,Minna Woo,Minna Woo,Anne Hakem,Anne Hakem,Andrew Wakeham,Andrew Wakeham,Julia Potter,Julia Potter,Armin Reitmair,Armin Reitmair,Filio Billia,Eduardo Firpo,Chi-chung Hui,James M. Roberts,Janet Rossant,Janet Rossant,Tak W. Mak,Tak W. Mak +24 more
TL;DR: The death of Brca1(5-6) mutant embryos prior to gastrulation may be due to a failure of the proliferative burst required for the development of the different germ layers, and the fact that mutant blastocyst growth is grossly impaired in vitro.
Journal ArticleDOI
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
Toshifumi Matsuyama,Toshifumi Matsuyama,Tohru Kimura,Tohru Kimura,Tohru Kimura,Motoo Kitagawa,Klaus Pfeffer,Klaus Pfeffer,Takatoshi Kawakami,Nobumasa Watanabe,Thomas M. Kündig,Ryuichi Amakawa,Ryuichi Amakawa,Kenji Kishihara,Kenji Kishihara,Andrew Wakeham,Andrew Wakeham,Julia Potter,Julia Potter,Caren Furlonger,Arumugavadivel Narendran,Haruhiko Suzuki,Haruhiko Suzuki,Pamela S. Ohashi,Christopher J. Paige,Tadatsugu Taniguchi,Tak W. Mak,Tak W. Mak +27 more
TL;DR: A profound reduction of TCR alpha beta+CD4-CD8+ T cells in IRF-1-deficient mice, with a thymocyte developmental defect, reveals a critical role for IRF -1 in T cell development.
Journal ArticleDOI
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function
Hans-Willi Mittrücker,Toshifumi Matsuyama,Alex Grossman,Thomas M. Kündig,Julia Potter,Arda Shahinian,Andrew Wakeham,Bruce Patterson,Pamela S. Ohashi,Tak W. Mak +9 more
TL;DR: Lymphocyte-specific interferon regulatory factor (LSIRF) (now called IRF4) is a transcription factor expressed only in lymphocytes that is essential for the function and homeostasis of both mature B and mature T lymphocytes.